patent ductus arteriosus. Patent ductus arteriosus
Conditions
Interventions
Intervention 1: Intervention group: morphin 0.1 mg/kg & lasix 0.5 mg/kg. Intervention 2: Control group: no drug.
Treatment - Drugs
Intervention group: morphin 0.1 mg/kg & lasix 0.5 mg/kg.
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: isolated PDA patient aged 1_12 years; moderate and sever pulmonary HTN. Exclusion criteria: another structural abnormality.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary edema. Timepoint: every 1 hour for 24 hr. Method of measurement: ausculation/ABG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypotension. Timepoint: each 15 min. Method of measurement: arterial line. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShohreh Beladi Behbahani
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed